Cargando…
Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents
Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) has been widely spread in the world with a high mortality. Cytokine storm syndrome (CSS) and acute lung injury caused by SARS-CoV-2 infection severely threaten the patients. With the purpose t...
Autores principales: | Su, Li, Tu, Ye, Kong, De-pei, Chen, Da-gui, Zhang, Chen-xi, Zhang, Wan-nian, Zhuang, Chun-lin, Wang, Zhi-bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443334/ https://www.ncbi.nlm.nih.gov/pubmed/32846329 http://dx.doi.org/10.1016/j.biopha.2020.110643 |
Ejemplares similares
-
Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
por: Zhang, Chen-xi, et al.
Publicado: (2022) -
Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm
por: Pontali, Emanuele, et al.
Publicado: (2023) -
A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
por: Cabrera-Andrade, Alejandro, et al.
Publicado: (2020) -
Screening of Microbial Natural Products and Biological Evaluation of Trichomicin as Potential Anti-Cytokine Storm Agents
por: Chen, Yu, et al.
Publicado: (2021) -
Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning
por: Gantla, Maanaskumar R., et al.
Publicado: (2023)